- Report
- June 2025
- 150 Pages
Global
From €2427EUR$2,699USD£2,080GBP
- Drug Pipelines
- June 2025
- 200 Pages
Global
From €2508EUR$2,789USD£2,150GBP
- Drug Pipelines
- June 2025
- 200 Pages
Global
From €2508EUR$2,789USD£2,150GBP
- Drug Pipelines
- June 2025
- 200 Pages
Global
From €2508EUR$2,789USD£2,150GBP
- Report
- May 2025
- 300 Pages
Global
From €4450EUR$4,949USD£3,814GBP
- Report
- August 2024
- 150 Pages
Global
From €2508EUR$2,789USD£2,150GBP
- Report
- June 2023
- 120 Pages
Asia Pacific
From €3479EUR$3,869USD£2,982GBP
- Report
- May 2023
- 160 Pages
Global
From €4450EUR$4,949USD£3,814GBP
- Report
- May 2023
- 147 Pages
Global
From €4450EUR$4,949USD£3,814GBP
- Report
- March 2023
- 147 Pages
Global
From €4450EUR$4,949USD£3,814GBP
- Report
- March 2023
- 147 Pages
Global
From €4450EUR$4,949USD£3,814GBP
- Drug Pipelines
- April 2025
- 240 Pages
Global
From €2697EUR$3,000USD£2,312GBP
- Drug Pipelines
- April 2025
- 60 Pages
Global
From €1124EUR$1,250USD£963GBP
- Report
- February 2024
- 181 Pages
Europe
From €4271EUR$4,750USD£3,661GBP
- Report
- May 2025
- 70 Pages
Japan
From €4271EUR$4,750USD£3,661GBP
- Report
- February 2024
- 70 Pages
United States
From €4271EUR$4,750USD£3,661GBP
- Report
- February 2024
- 70 Pages
China
From €4271EUR$4,750USD£3,661GBP
- Report
- February 2024
- 70 Pages
Thailand
From €4271EUR$4,750USD£3,661GBP
- Report
- February 2024
- 70 Pages
Philippines
From €4271EUR$4,750USD£3,661GBP
- Report
- February 2024
- 70 Pages
Oman
From €4271EUR$4,750USD£3,661GBP

The insulin market is a subset of the larger endocrine and metabolic disorders drugs market. Insulin is a hormone produced by the pancreas that helps regulate the body's blood sugar levels. It is used to treat diabetes, a condition in which the body does not produce enough insulin or is unable to use it effectively. Insulin is available in both short-acting and long-acting forms, and is typically administered via injection or an insulin pump.
The insulin market is highly competitive, with a number of major pharmaceutical companies offering a variety of insulin products. These include Eli Lilly, Novo Nordisk, Sanofi, and Merck. Additionally, there are a number of smaller companies that specialize in the production of insulin, such as Biocon, Wockhardt, and Wockhardt USA. Show Less Read more